Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma Group (MREO) Return on Assets: 2024-2025

Historic Return on Assets for Mereo BioPharma Group (MREO) over the last 2 years, with Sep 2025 value amounting to -0.72%.

  • Mereo BioPharma Group's Return on Assets fell 23.00% to -0.72% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.72%, marking a year-over-year decrease of 23.00%. This contributed to the annual value of -0.61% for FY2024, which is 20.00% down from last year.
  • Latest data reveals that Mereo BioPharma Group reported Return on Assets of -0.72% as of Q3 2025, which was up 5.47% from -0.76% recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma Group's Return on Assets registered a high of -0.43% during Q1 2024, and its lowest value of -0.76% during Q2 2025.
  • For the 2-year period, Mereo BioPharma Group's Return on Assets averaged around -0.58%, with its median value being -0.52% (2024).
  • Data for Mereo BioPharma Group's Return on Assets shows a maximum YoY fell of 27bps (in 2025) over the last 5 years.
  • Over the past 2 years, Mereo BioPharma Group's Return on Assets (Quarterly) stood at -0.52% in 2024, then dropped by 23bps to -0.72% in 2025.
  • Its Return on Assets stands at -0.72% for Q3 2025, versus -0.76% for Q2 2025 and -0.65% for Q1 2025.